Alignment Healthcare (ALHC) Projected to Release Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is expected to be posting its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect Alignment Healthcare to announce earnings of ($0.0389) per share and revenue of $1.31 billion for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, October 29, 2026 at 5:00 PM ET.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. The business’s revenue for the quarter was up 31.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.07 earnings per share. On average, analysts expect Alignment Healthcare to post $0.14 EPS for the current fiscal year and $0.30 EPS for the next fiscal year.

Alignment Healthcare Trading Up 2.0%

Shares of NASDAQ:ALHC opened at $8.05 on Wednesday. The stock has a fifty day simple moving average of $10.18 and a two-hundred day simple moving average of $17.02. The stock has a market capitalization of $1.67 billion, a price-to-earnings ratio of 42.37 and a beta of 1.14. Alignment Healthcare has a 12-month low of $6.01 and a 12-month high of $25.12.

Wall Street Analyst Weigh In

ALHC has been the topic of several recent analyst reports. KeyCorp cut their price objective on shares of Alignment Healthcare from $28.00 to $12.00 and set an “overweight” rating on the stock in a research report on Friday, October 9th. Raymond James Financial reaffirmed an “outperform” rating on shares of Alignment Healthcare in a report on Monday, October 12th. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Barclays cut their price target on shares of Alignment Healthcare from $16.00 to $10.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 6th. Seven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $15.91.

Insider Activity at Alignment Healthcare

In other news, President Dawn Maroney sold 122,707 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the completion of the transaction, the president directly owned 794,606 shares of the company’s stock, valued at $10,075,604.08. The trade was a 13.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO John Kao sold 27,400 shares of the business’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $13.00, for a total transaction of $356,200.00. Following the transaction, the chief executive officer directly owned 590,766 shares of the company’s stock, valued at $7,679,958. The trade was a 4.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,061,967 shares of company stock worth $13,642,490. 5.20% of the stock is owned by insiders.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled health insurance company focused on providing Medicare Advantage plans for seniors. The company combines health plan coverage with care coordination and clinical services designed to help members manage chronic conditions, access providers and navigate the health care system.

Its offerings include Medicare Advantage plans, supplemental benefits and member support services. Alignment also uses its proprietary technology platform, including the Alignment Virtual Application (AVA), to support care teams, analyze health information and help deliver more personalized services to members.

Founded in 2013, Alignment Healthcare serves Medicare-eligible consumers in selected markets, including California, Florida, Nevada and North Carolina.